Other substances

Quinoline,1,2,3,4-tetrahydro-1-[(2-phenylcyclopropyl)sulfonyl]-trans-(8CI)

A protease inhibitor.

Phase of research

Potential treatment - theoretical effect

How it helps

Antiviral

Drug status

Experimental

1
 Supporting references
0
 Contradictory references
0
 AI-suggested references
0
 Clinical trials

General information

1-(2-Phenylcyclopropyl)sulfonyl-3,4-dihydro-2H-quinoline isomer. 

Quinoline,1,2,3,4-tetrahydro-1-[(2-phenylcyclopropyl)sulfonyl]-trans-(8CI) on GuideChem

 

 

Structure image - Quinoline,1,2,3,4-tetrahydro-1-[(2-phenylcyclopropyl)sulfonyl]-trans-(8CI)

C1CC2=CC=CC=C2N(C1)S(=O)(=O)C3CC3C4=CC=CC=C4

Supporting references

Link Tested on Impact factor Notes Publication date
Quinolines-Based SARS-CoV-2 3CLpro and RdRp Inhibitors and Spike-RBD-ACE2 Inhibitor for Drug-Repurposing Against COVID-19: An in silico Analysis
in silico 4.24

Predicted to interact with the active site of SARS-CoV-2 3C-like protease.

 Jul/23/2020
Export (.csv)